
United States President Donald Trump’s early actions on healthcare signal his likely intention to wipe away some Biden-era programmes to lower drug costs and expand coverage under public insurance programmes.
The orders he issued soon after re-entering the White House have policymakers, healthcare executives and patient advocates trying to read the tea leaves to determine what’s to come. The directives, although less expansive than orders he issued at the beginning of his first term, provide a possible road map that health researchers say could increase the number of uninsured Americans and weaken safety net protections for low-income people.